Nrf2 signaling in heart failure: expression of Nrf2, Keap1, antioxidant, and detoxification genes in dilated or ischemic cardiomyopathy
- 1 March 2022
- journal article
- research article
- Published by American Physiological Society in Physiological Genomics
- Vol. 54 (3) , 115-127
Abstract
Increased levels of oxidative stress have been found with heart failure. Whether failing hearts express antioxidant and detoxification enzymes have not been addressed systematically. Nrf2 gene encodes a transcription factor that regulates the expression of antioxidant and detoxification genes. Using RNA-Seq data set from explanted hearts of 37 patients with dilated cardiomyopathy (DCM), 13 patients with ischemic cardiomyopathy (ICM), and 14 nonfailure (NF) donors as a control, we addressed whether failing hearts change the expression of Nrf2, its negative regulator Keap1, and antioxidant or detoxification genes. Significant increases in the ratio of Nrf2 to Keap1 were found to associate with DCM or ICM. Antioxidant genes showed decreased expression in both types of heart failure, including NQO1, SOD1, GPX3, GPX4, GSR, PRDX1, and TXNRD1. Detoxification enzymes, GCLM and EPHX1, also showed decreased expression, whereas the CYP1B1 transcript was elevated in both DCM and ICM. The genes encoding metal-binding protein ferritin were decreased, whereas five out of 12 metallothionein genes showed elevated expression. Our finding on Nrf2 gene expression has been validated by meta-analysis of seven independent data sets of microarray or RNA-Seq for differential gene expression in DCM and ICM from NF controls. In conclusion, minor elevation of Nrf2 gene expression is not coupled to increases in antioxidant and detoxification genes, supporting an impairment of Nrf2 signaling in patients with heart failure. Decreases in multiple antioxidant and detoxification genes are consistent with the observed increases of oxidative stress in failing hearts.Keywords
Funding Information
- HHS | NIH | National Institute of General Medical Sciences (R01 GM126165)
- HHS | NIH | National Institute of General Medical Sciences (R01 GM125212)
- University of Arizona College of Pharmacy
This publication has 55 references indexed in Scilit:
- Differential Gene Expression of Cardiac Ion Channels in Human Dilated CardiomyopathyPLOS ONE, 2013
- STAR: ultrafast universal RNA-seq alignerBioinformatics, 2012
- La Autoantigen Mediates Oxidant Induced De Novo Nrf2 Protein TranslationMolecular & Cellular Proteomics, 2012
- RNA-SeQC: RNA-seq metrics for quality control and process optimizationBioinformatics, 2012
- RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genomeBMC Bioinformatics, 2011
- Diminished Antioxidant Activity of High-Density Lipoprotein–Associated Proteins in Systolic Heart FailureCirculation: Heart Failure, 2011
- Cytochrome P450 1B1 Contributes to Angiotensin II–Induced Hypertension and Associated PathophysiologyHypertension, 2010
- Cardiac-Specific Overexpression of Catalase Identifies Hydrogen Peroxide-Dependent and -Independent Phases of Myocardial Remodeling and Prevents the Progression to Overt Heart Failure in Gαq-Overexpressing Transgenic MiceCirculation: Heart Failure, 2010
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression dataBioinformatics, 2009
- Prostaglandins in Severe Congestive Heart FailureNew England Journal of Medicine, 1984